A Phase II Study of Daratumumab in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma Who Received One Prior Line of Therapy (KMM1906).
Saved in:
| Title: | A Phase II Study of Daratumumab in Combination with Bortezomib and Dexamethasone in Patients with Multiple Myeloma Who Received One Prior Line of Therapy (KMM1906). |
|---|---|
| Authors: | Yoo, Kwai Han1 (AUTHOR), Yoon, Sang Eun2 (AUTHOR), Kang, Ka-Won3 (AUTHOR), Yi, Jun Ho4 (AUTHOR), Kim, Min Kyoung5 (AUTHOR), Kim, Hyo Jung6 (AUTHOR), Kim, Sung-Hyun7 (AUTHOR), Park, Joon Seong8 (AUTHOR), Jung, Sung-Hoon9 (AUTHOR), Lee, Je-Jung9 (AUTHOR), Min, Chang-Ki10 (AUTHOR), Lee, Jae Hoon1 (AUTHOR), Cho, Duck11 (AUTHOR), Kim, Kihyun2 (AUTHOR) kihyunk@skku.edu |
| Source: | Cancer Research & Treatment. Jul2026, Vol. 58 Issue 3, p963-970. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 15982998 |
|---|---|
| DOI: | 10.4143/crt.2025.426 |
